The FDA approved ensartinib (Ensacove) as a first-line treatment for adults with ALK -positive locally advanced or metastatic ...
Ensartinib has received FDA approval for the first-line treatment of ALK-positive locally advanced or metastatic non–small ...
Microgravity is known to alter the muscles, bones, the immune system and cognition, but little is known about its specific impact on the brain.
Russia announces the development of an mRNA cancer vaccine, slated for a 2025 launch. Pre-clinical trials demonstrate tumor ...
The FastGlioma tool could enable rapid and accurate detection of microscopic tumour infiltration, improving the success of ...
The addition of atezolizumab to neoadjuvant chemotherapy failed to significantly improve event-free survival in patients with ...
A recent University of Kentucky Markey Cancer Center study highlights a radiation therapy technique that treats brain tumors ...
Dr Michelle Melisko discusses the challenging aspects involved in decision-making around screening for brain metastasis in ...
Cancer is one of the most formidable health challenges of our time, affecting nearly half of us during our lives. While treatments have significantly improved in recent decades, the biggest challenge ...
Recent cancer treatment breakthroughs include FDA approvals for zenocutuzumab and durvalumab, and sacituzumab tirumotecan gained breakthrough therapy status. In addition, sonodynamic therapy shows ...
Researchers have developed a method to program immune cells to target glioblastoma and reduce inflammation associated with ...
Researchers presented data from trials of HER2-targeted therapies from Jiangsu Hengrui Medicine, Jazz Pharma, Roche, and RemeGen.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback